ANIX logo

Anixa Biosciences, Inc.

ANIX
Healthcare|Biotechnology|US
$3.17
+0.14 (+4.79%)
DCF Value
$0.03
Tangible Book / Share
$0.39
Cash / Share
$0.41
Next Earnings Report
Jan 11, 2027
EPS est. -$0.08
Financing Filings (last 12 months)
0
No shelf registrations or offering prospectuses filed.

Upcoming Data Readouts (0)

No upcoming completion dates found in active trials.

Recent Press Releases

Anixa Biosciences Announces Presentation of Ovarian Cancer CAR-T Clinical Trial at ESMO Immuno-Oncology & Advanced Therapies Congress 2026
Nov 4, 2026 · PRNewsWire
Anixa Biosciences Announces Completion of Treatment of Fifth Cohort in its Ovarian Cancer CAR-T Clinical Trial
Oct 26, 2026 · PRNewsWire
Anixa Biosciences' Ovarian Cancer CAR-T Therapy Inventor to Deliver Keynote at Ovarian Cancer Midwest Focus Conference
Oct 13, 2026 · PRNewsWire
Anixa Biosciences Announces First Case of Stable Disease for Three Months in Ovarian Cancer CAR-T Clinical Trial
Oct 5, 2026 · PRNewsWire
Anixa Biosciences Announces Treatment of Second Patient in the Fifth Cohort of its Ovarian Cancer CAR-T Clinical Trial
Oct 1, 2026 · PRNewsWire
Anixa Biosciences Granted First Australian Patent for its Breast Cancer Vaccine, Broadening Global Protection Through 2040
Sep 21, 2026 · PRNewsWire
Anixa Biosciences Appoints UPenn's Dr. Carmen Guerra to Cancer Business Advisory Board
Sep 16, 2026 · PRNewsWire
Anixa Biosciences Interview Highlighting Breast Cancer Vaccine to Air on the RedChip Small Stocks, Big Money™ Show on Bloomberg TV
Sep 9, 2026 · PRNewsWire
Anixa Biosciences to Present at the Nasdaq & LD Micro Inaugural SF Summit on September 9, 2026
Sep 3, 2026 · PRNewsWire
Anixa Biosciences to Present at the 2026 Cantor Fitzgerald Global Healthcare Conference Highlighting its Breast Cancer Vaccine and Ovarian Cancer CAR-T Therapy
Aug 24, 2026 · PRNewsWire

SEC Filings (21)

Last two years from EDGAR. Insider Form 4s are on the Ownership tab.

FiledFormWhat it isLinks
Sep 9, 202610-QQuarterly reportDocumentIndex
Jun 10, 202610-QQuarterly reportDocumentIndex
Mar 11, 20268-KMaterial eventDocumentIndex
Mar 9, 202610-QQuarterly reportDocumentIndex
Feb 9, 20268-KMaterial eventDocumentIndex
Jan 28, 2026DEF 14AProxy / shareholder voteDocumentIndex
Jan 12, 2026S-8Employee stock planDocumentIndex
Jan 12, 202610-KAnnual reportDocumentIndex
Jan 6, 2026SC 13D/AActivist / 5%+ stakeDocumentIndex
Dec 12, 20258-KMaterial eventDocumentIndex
Sep 30, 2025EFFECTDocumentIndex
Sep 10, 2025S-3Shelf registrationDocumentIndex
Sep 10, 202510-QQuarterly reportDocumentIndex
Jun 6, 2025SC 13D/AActivist / 5%+ stakeDocumentIndex
May 28, 202510-QQuarterly reportDocumentIndex
Mar 21, 20258-KMaterial eventDocumentIndex
Mar 11, 202510-QQuarterly reportDocumentIndex
Feb 6, 2025DEF 14AProxy / shareholder voteDocumentIndex
Jan 10, 2025S-8Employee stock planDocumentIndex
Jan 10, 202510-KAnnual reportDocumentIndex
Jan 3, 2025SC 13D/AActivist / 5%+ stakeDocumentIndex